Livestock Dewormers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Cattle, Swine, Poultry, Other), By Mode of Administration (Oral, Topical, Other), By Region, By Competition 2020-2030F

Market Overview

The Global Livestock Dewormers Market will grow from USD 7.25 Billion in 2024 to USD 9.23 Billion by 2030 at a 4.11% CAGR. Livestock dewormers encompass anthelmintic chemicals or pharmaceutical agents administered to livestock for the prevention or elimination of helminth parasites such, as flukes, roundworms, and tapeworms, thereby safeguarding animal health and productivity. The market's expansion is fundamentally driven by a surging global population and the concomitant increase in demand for animal protein, necessitating intensive livestock farming practices to meet consumption needs. Furthermore, the persistent prevalence of parasitic infections in livestock, leading to substantial economic detriments for agricultural producers, alongside continuous advancements in veterinary medicine, robustly supports market growth.

According to MSD Animal Health, at the World Buiatrics Congress in 2024, farmers in major cattle-producing regions globally incurred losses exceeding US$21 billion annually due to parasites. This underscores the critical need for effective deworming solutions. A significant challenge impeding market expansion, however, is the escalating issue of anthelmintic resistance, wherein parasites develop reduced susceptibility to existing deworming compounds, diminishing treatment efficacy.

Key Market Drivers

The rising global demand for animal protein significantly influences the livestock dewormers market by necessitating larger, more intensively managed animal populations to meet escalating consumption needs. This persistent demand drives farmers to maximize productivity and minimize disease-related losses, making deworming solutions essential for maintaining animal health and optimizing output. According to a joint forecast by the OECD and the Food and Agriculture Organization (FAO), in July 2025, global meat consumption is projected to grow by 47.9 million tons over the next decade, highlighting the continuous pressure on livestock producers to enhance efficiency. Concurrently, the high prevalence of parasitic infections in livestock presents a significant and ongoing challenge that directly underpins the demand for dewormers. Parasites lead to substantial economic losses through reduced feed conversion, lower production, impaired fertility, and increased mortality. These infections compromise animal welfare and threaten food security and farm profitability. According to MSD Animal Health, in May 2024, losses due to parasites for farmers in major cattle-producing regions globally exceed US$21 billion annually, underscoring the critical economic impact of these infections and the indispensable role of effective deworming interventions.

The urgent need to mitigate these substantial economic and health burdens positions livestock dewormers as indispensable tools within modern animal husbandry practices. Continuous innovation in product formulations and delivery methods by leading animal health companies further supports market expansion, providing more effective and easier-to-administer treatments. According to Boehringer Ingelheim, in July 2025, their Animal Health Business' parasiticide portfolio, particularly the NEXGARD® brand, grew by 7.9% in the first half of 2025, reflecting sustained industry focus and farmer adoption of these essential products for safeguarding livestock health and ensuring sustainable animal protein production globally.

Download Free Sample Report

Key Market Challenges

Anthelmintic resistance represents a critical challenge significantly impeding the growth of the Global Livestock Dewormers Market. This issue arises when helminth parasites develop a reduced susceptibility to existing deworming compounds, thereby diminishing the effectiveness of treatments. Consequently, the ability of conventional dewormers to effectively prevent or eliminate parasitic infections in livestock is compromised. This reduced efficacy directly leads to persistent infections, resulting in decreased animal health, impaired growth rates, and substantial productivity losses across various livestock sectors.

The diminishing returns from deworming treatments directly hamper market expansion by eroding farmer confidence in existing products. Producers observing reduced efficacy are less inclined to invest in solutions perceived as failing, which can lead to decreased purchase volumes and delayed treatments. For example, according to Awanui Veterinary, in 2024, 51% of *Trichostrongylus* cases on tested New Zealand sheep farms exhibited resistance to triple combination anthelmintics. This substantial prevalence of resistance illustrates how the declining effectiveness of deworming compounds directly constrains market growth by undermining the fundamental value and reliability of current anthelmintic solutions.

Key Market Trends

Anthelmintic Resistance Management Innovations represent a significant trend in the global livestock dewormers market, driven by the escalating challenge of drug resistance in parasitic populations. This trend focuses on the development of novel anthelmintic compounds, alternative treatment methodologies, and advanced management strategies to restore and prolong the efficacy of deworming interventions. The industry's commitment to addressing this critical issue is substantial, with HealthforAnimals indicating that the global animal health sector aims to invest at least $10 billion in research and development by 2025, encompassing efforts to deliver new solutions across various animal health challenges, including parasite control. This investment is crucial for safeguarding animal productivity and welfare. Boehringer Ingelheim, in its "Outlook for 2025 – Partnering for Innovation in Animal Health," emphasized their dedication to advancing breakthrough science and investing in external innovation to address unmet needs and improve animal health and well-being.

Precision Deworming and Diagnostic Tool Integration marks a crucial evolution in livestock parasite control, shifting from routine prophylactic treatments to targeted, data-driven approaches. This trend leverages advanced diagnostic technologies to accurately identify specific parasitic burdens and their resistance profiles within herds, enabling tailored treatment regimens. Such precision minimizes unnecessary drug administration, reduces selection pressure for anthelmintic resistance, and optimizes treatment effectiveness, leading to enhanced animal health outcomes and more sustainable production. Supporting this shift, HealthforAnimals has outlined an industry objective to deliver 20 new diagnostic tools by 2025 as part of broader innovation efforts in animal health. The World Veterinary Association's Annual Report of Activities, published in July 2025, highlighted the upcoming World Veterinary Association Congress 2025, which will feature a Seminar on Medicines Stewardship, underscoring the growing importance of responsible and precise medication use in veterinary practice.

Segmental Insights

The "Cattle" segment is a primary driver in the Global Livestock Dewormers Market, experiencing rapid growth due to the significant role of cattle in global agriculture and dairy production. This segment's expansion is fueled by the inherent susceptibility of cattle to various parasitic infections, which directly impact their health, growth rates, and milk yield, leading to substantial economic losses for farmers. Furthermore, the escalating global demand for beef and dairy products necessitates robust parasite control measures to ensure optimal animal productivity and meet market requirements. Increased awareness among livestock farmers regarding animal welfare and the economic benefits of regular deworming, coupled with supportive government initiatives and stringent food safety regulations from bodies like the Food and Agriculture Organization (FAO), further propel the demand for cattle-specific dewormers.

Regional Insights

North America leads the global livestock dewormers market, driven by its well-established and technologically advanced livestock industry, which encompasses significant cattle, swine, and poultry production. Farmers in the region increasingly prioritize animal health and welfare, fostering a strong demand for effective deworming solutions to ensure optimal livestock productivity. This dominance is further underpinned by stringent regulatory frameworks and rigorous quality standards, exemplified by the U.S. Food and Drug Administration's oversight, which promotes advanced deworming practices and continuous product innovation. Moreover, heightened awareness among livestock owners regarding the economic implications of parasitic infections, alongside proactive animal healthcare initiatives and veterinary disease awareness programs, collectively contributes to the region's prominent market position.

Recent Developments

• In October 2025, Zoetis Inc. received conditional approval from the U.S. Food and Drug Administration (FDA) for Dectomax-CA1 Injectable, a new parasite control product. This solution is specifically designed for the prevention and treatment of New World screwworm infestations in cattle. The conditional approval allows for its use in beef cattle, young female dairy cattle, pregnant beef cows, newborn calves, and bulls, with a 21-day prevention against reinfestation. This product addresses a significant threat to livestock producers, particularly as the New World screwworm continues its northward expansion. The new injectable is expected to be available with its updated label in early 2026.

• In June 2025, BioInnovate Africa reported on pharmaceutical scientist Rashidah Kaggwa's fellowship experience, focused on developing a herbal dewormer for improved livestock production. Collaborating with Jomo Kenyatta University of Agriculture and Technology and interning at VetCare Africa, a pharmaceutical manufacturing company, she engaged in research and development. The project involved nanoencapsulation of bromelain and conducting goat farm trials for a drug named Bromecure, aimed at enhancing livestock health. This research represents a significant step in exploring alternative, sustainable deworming solutions and contributing to innovation within the global livestock dewormers market.

• In May 2025, Bimeda announced the expansion of its anti-parasitic product portfolio in the U.S. with the introduction of Doracide™ (doramectin topical solution). This new pour-on dewormer is indicated for use in livestock and represents an addition to the company's existing range of parasiticides. The launch of Doracide™ strengthens Bimeda's offerings for animal health professionals, providing an alternative bioequivalent solution for controlling various internal and external parasites in cattle. This product aims to support livestock health management strategies by offering a convenient and effective treatment option for producers.

• In 2024 and continuing into 2025, Micron Agritech advanced its breakthrough research in animal diagnostics with the development and expansion of its AI-powered Micron Kit. This technology offers rapid, lab-accurate faecal egg count and fluke test results for ruminant and equine samples within minutes. By enabling veterinarians and animal health professionals to analyze animals for parasites efficiently, the Micron Kit facilitates targeted deworming strategies. This innovation helps identify the specific dewormer needed, thereby combating the growing challenge of anthelmintic resistance and promoting sustainable parasite control in livestock populations.

Key Market Players

• Bayer AG
• Boehringer Ingelheim GmbH
• Durvet, Inc.
• Elanco Animal Health Inc
• First Priority, Inc.
• Jeffers, Inc.
• Manna Pro Products, LLC
• Merck & Co Inc.
• Virbac
• Zoetis Inc.

Report Scope:

In this report, the Global Livestock Dewormers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Livestock Dewormers Market, By Animal Type:

o   Cattle

o   Swine

o   Poultry

o   Other

• Livestock Dewormers Market, By Mode of Application:

o   Oral

o   Topical

o   Other

• Livestock Dewormers Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Livestock Dewormers Market.

Available Customizations:

Global Livestock Dewormers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Livestock Dewormers Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]